We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
59.00 | 3.18% | 1,913.00 | 1,916.00 | 1,918.00 | 1,920.00 | 1,861.00 | 1,861.00 | 522,491 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.08 | 4.24B |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2017 16:04 | Keep waiting for this to trend sideways before considering a purchase, but it keeps falling. 900p not all that far away. | its the oxman | |
09/11/2017 20:55 | Surprised to see that they still have a major disagreement with FDA. It will be great if they can resolve the issue in Q1 2018 . | karateboy | |
09/11/2017 14:05 | Could have been a shorters last hurrah before the big boys pile back in. The FDA problems started this slide. If it gets sorted out the upside should be excellent. Time will tell as always.... | bantam175 | |
09/11/2017 09:24 | awful stuff, I do not understand why institutions were buying so heavily recently - they are losing millions - they haven't got a clue. maybe a bounce in coming days? | chc15 | |
09/11/2017 09:10 | Buy note out from Numis this morning £13 | nortic 007 | |
09/11/2017 08:42 | Hard to believe there was a broker forecast of £35 earlier this year. | bantam175 | |
09/11/2017 08:36 | PER still looks generous imv, however there may be more sector consolidation at some point imv. | essentialinvestor | |
09/11/2017 08:15 | Bant - agree. Hikma Pharmaceuticals has revised its full year expectations for its generics business but continues to expect full year revenue to be around $2.0bn in constant currency. The group said its injectables and branded businesses were delivering a good performance but like many of its competitors, it was experiencing challenging conditions in the US generics market. | broadwood | |
09/11/2017 08:08 | This is nuts. They continue to expect full year revenue to be around $2.0 billion in constant currency in 2017 and get a drop like this? | bantam175 | |
09/11/2017 07:52 | Panmure calling it down 5% .... see what the mkt thinks...... One to keep on the watch list if it gets really ugly but nothing in there today which screams falls overdone etc....IMO | soundbuy | |
09/11/2017 07:42 | I sincerely hope so - it was £22 and now almost £10. One hell if a drop. Suet | suetballs | |
09/11/2017 07:38 | Is this all in the price? | broadwood | |
09/11/2017 07:33 | Not fast growing anymore! Significant headwinds. Doh! Suet | suetballs | |
08/11/2017 18:00 | Trading update tomorrow - hopeful for some encouraging news. Suet | suetballs | |
08/11/2017 15:50 | The pain continues. Suet | suetballs | |
07/11/2017 16:19 | What caused the fall? | celeritas | |
07/11/2017 15:52 | If it break £10 then I see the next stop around 7.50 That's where i am targeting my buy in Gla | specul82 | |
07/11/2017 15:30 | Electronic order book surely. You can buy GILD or Shire on around 11-12x- depending on which figures you use, with the advantages of product patent protection. Perhaps Hikma is worth more to someone else(would expect sector consolidation) or to one of the major shareholders, otherwise it does not look particularly cheap to me. Just my view only, may be wrong. | essentialinvestor | |
07/11/2017 15:23 | who knows, getting beat up again, the MM's playing games. Gotta be a takeover target too now. | chc15 | |
07/11/2017 14:43 | I suspect it won't gain 50% in two months. I do suspect that it will reach a price at which it is oversold, 9 quid is getting closer... | andyj | |
07/11/2017 07:31 | This will be back up in the £15 margin by January I suspect. Good luck with your £9 | gozzy90 | |
07/11/2017 00:06 | I am hanging on for 9 quid. | andyj | |
06/11/2017 19:35 | As I have said before, this is a value buy now, and there has been a big buyer in the background. I'm staying put, and adding if goes lower. | chc15 | |
06/11/2017 16:02 | New PPI products approved by FDA and raising of prices of its US products should help drive growth. | justiceforthemany | |
06/11/2017 16:01 | Drop from 2300p to 1080p seems unjustified IMO | justiceforthemany |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions